February 2018 Issue of MMM

February 2018 Issue of MMM

Go Figure

Infographic | Highlighting top healthcare trends

There was so much bigger-picture coverage of pharma and healthcare in 2017 - pricing, Affordable Care Act reform and repeal - that it was easy ...

Editor's Desk

MM&M's Data Week: Demystifying one of pharma's biggest pain points

It was at an MM&M event back in late 2013 that I got my first glimpse of how this industry feels about big data.

Digital Edition

Read the February 2018 Digital Edition

Read the February 2018 issue in its entirety.

Features

High five: How these companies are leveraging data to engage A-list HCPs

In the past, pharma hasn't used data effectively to engage its A-list HCPs. Five companies hope to change that.

Real-world evidence: It's finally having its moment

Fueled by system-wide demand and facilitated by AI, the industry's lofty expectations around real-world evidence could soon be fulfilled

Big Predictions: Agency gurus on the future of data in the industry

We asked some of the agency world's sharpest data people to answer a pair of questions about the future of data in and around pharma ...

Get to know your data scientist: Four data aces share their knowledge

Four data aces share their backgrounds, inspirations, and guiding philosophies

As CAR-Ts go from candidates to brands, what's the marketing strategy?

Strategies for differentiating CAR-T therapies emerge in the early days of 2018, while competitors race to catch up with Novartis and Gilead.

10 myths about millennials and their healthcare habits

More has been written about millennials — and their healthcare habits — than about any other generation. Here, Gen Y marketers explain why most of ...

Headliner

2018 MAHF: Leverte 'was as good with clients as anyone you've ever seen'

Zero people have such tales about Robert Leverte, which is why news of his pending induction into the Medical Advertising Hall of Fame was received ...

Upward Move

McCann Health promotes Marcus Sigurdsson to global chief digital officer

Sigurdsson is charged with leading the agency's digital offering to meet growing client demand.

Partner Forum

How should pharma mine electronic health records as a data source?

At a time when value-based healthcare is a more common objective among stakeholders, EHR data can enable collaboration among payers, providers, health systems, and pharma ...

Beltway Insider

Scanning FDA's New Approach to Digital Health

FDA Commissioner Dr. Scott Gottlieb has been saying all the right things regarding digital health.

Viewpoint

Machine Learning Helps Marketers

For some, the term machine learning may conjure up images of virtual assistants or automated tools.

Private View

6 Campaigns that Talk to, Not at, Patients

Rather than talking at them, we need to design with and for them.

At Work With

Mitsubishi Tanabe's Kevin O'Brien on driving unmet needs

The VP of market access at Mitsubishi Tanabe Pharma America discusses driving access and bringing to market the first FDA-approved ALS drug in years.

Back Talk

Did Congress just kill the Orphan Drug Act?

By allowing companies to claim a 50% tax credit for qualified clinical testing expenses, developing drugs for rare diseases became economically feasible for the first ...